Cancer Clinical Trial
Official title:
Online Questionnaire Pre-Test Study
Verified date | April 2020 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Background:
The Division of Cancer Epidemiology and Genetics does research into the causes of cancer and
ways to prevent it. It uses data from questionnaires. Sometimes, pre-testing a questionnaire
with a group of volunteers can help researchers find errors in it and learn ways to improve
it.
Objectives:
To test a questionnaire for problems that might cause response errors and to develop ideas
for improving it. To test how long it takes people to complete it.
Eligibility:
Adults ages 35-75. Volunteers both with and without a history of tobacco use and with or
without a family history of cancer are needed.
Design:
Participants will be screened with a phone call.
Participants will be told what background data to bring to the 1 study visit.
An interviewer will give the participants the questionnaire. It will be done with pen and
paper. It will take about 1 hour.
There will be multiple-choice and open-ended questions. They will be about lifestyle,
medical, and environmental factors. Some of the questions will be about possibly illegal or
highly sensitive behaviors.
Participants will note any questions that they find hard to answer for any reason. They will
be asked to answer the best they can, but they can skip any question that they prefer not to
answer.
The personal data of participants will be deleted when the study is done.
The interviewer will observe participants while they do the questionnaire. He or she will
look for things like long pauses and confusion.
Participants will discuss the exam with the interviewer after they finish. This will take
about 1 hour.
Status | Completed |
Enrollment | 30 |
Est. completion date | April 2, 2020 |
Est. primary completion date | June 25, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 75 Years |
Eligibility |
- ELIGIBILITY CRITERIA: - Age 35 to 75 - Men or women - Fluent in English - Able to come to the SSS Durham, NC offices for the in-person interview - Able to provide informed consent |
Country | Name | City | State |
---|---|---|---|
United States | Social & Scientific Systems, INC | Durham | North Carolina |
Lead Sponsor | Collaborator |
---|---|
National Cancer Institute (NCI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Understanding of the Questionnaire | Response errors and comments on interpretation of questions and response categories, and the duration needed to complete the questionnaire modules. | Time of Interview |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|
||
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|